Clinical Trials Directory

Trials / Unknown

UnknownNCT06067386

Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
3,000 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The control of antibiotic resistance requires a reduction in inappropriate prescriptions of broad-spectrum antibiotics (amoxillin-clavulanate (AMC), fluoroquinolones (FQ), third-generation cephalosporins (C3G)), particularly for urinary tract infections treated in primary care. Several studies have reported the positive impact of antibiotic susceptibility testing performed on urine cultures on the appropriate use of antibiotics. The "selective reporting for antibiotic susceptibility testing ", defined as the restriction of the list of antibiotics mentioned in the report according to the antibiotic resistance profile, would allow, according to observational studies, a reduction of 25 to 70% of the initial prescriptions of broad-spectrum antibiotics and a 20% rate of antibiotic de-escalation (=reduction of the antibacterial spectrum of an antibiotic treatment after re-evaluation). The objective is to assess the impact of disseminating a selective reporting for antibiotic susceptibility testing on the dispensing of broad-spectrum antibiotics prescribed by general practitioners (GPs) for E. coli positive urine cultures in adult women, compared to the dissemination of a standard antibiotic susceptibility testing.

Conditions

Interventions

TypeNameDescription
OTHERDissemination of a selective reporting for antibiotic susceptibility testingFor each E. coli positive urine culture analyzed by LabOuest, GPs will receive an antibiotic susceptibility testing report, with the list of antibiotics restricted according to four E. coli susceptibility profiles, with an emphasis on narrower-spectrum antibiotics. The selected antibiotic susceptibility testing was developed following a targeted literature review and consultation with a steering committee including GPs, biologists and infectiologists. At the GP's request, a full antibiogram can be provided.
OTHERStandard antibiotic susceptibility testing reportGPs will receive a standard antibiotic susceptibility testing report for each E. coli positive urine culture.

Timeline

Start date
2023-11-21
Primary completion
2024-11-21
Completion
2024-11-21
First posted
2023-10-04
Last updated
2024-04-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06067386. Inclusion in this directory is not an endorsement.